Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
NEW CRYSTAL FORM OF β-NICOTINAMIDE MONONUCLEOTIDE, PREPARATION METHOD THEREFOR AND USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2022/033589
Kind Code:
A1
Abstract:
The present invention relates to a new crystal form of β-nicotinamide mononucleotide represented by formula (I) and a preparation method therefor. The method of the present invention does not use toxic and harmful organic solvents such as methanol, is simple to operate, is safe for production personnel, and is environmentally friendly. The new crystal form of the present invention has high crystal purity and good stability. (I)

Inventors:
LI QIANG (CN)
CHEN XUANFU (CN)
LIU XIANGQUN (CN)
Application Number:
PCT/CN2021/112598
Publication Date:
February 17, 2022
Filing Date:
August 13, 2021
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
CHANGZHOU BOHIV PHARMACEUTICAL TECH CO LTD (CN)
International Classes:
C07H19/048; A61K31/706; C07H1/06
Domestic Patent References:
WO2018047715A12018-03-15
Foreign References:
CN112538101A2021-03-23
CN111705096A2020-09-25
CN113402570A2021-09-17
CN113121628A2021-07-16
CN112694505A2021-04-23
CN110195089A2019-09-03
CN111377983A2020-07-07
US20180134742A12018-05-17
CN108697722A2018-10-23
Other References:
DENG, JUN ET AL.: "Clinical Research and Chemical Preparation Progress of Nicotinamide Nucleotide", GUANGDONG CHEMICAL INDUSTRY, vol. 48, no. 12, 25 June 2021 (2021-06-25), pages 98 - 100,88, XP055900260
Attorney, Agent or Firm:
XU&PARTNERS, LLC. (CN)
Download PDF: